Lipid signaling in pathogenic fungi

Annual Review of Microbiology

Volumn 63, Issue , 2009, Pages 119-131

  Rhome, Ryan ^a   Del Poeta, Maurizio ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Aspergillus; Candida; Cryptococcus; Farnesol; Prostaglandin; Sphingolipid

Indexed keywords

ADENYLATE CYCLASE; ANTIFUNGAL AGENT; CERAMIDE DERIVATIVE; DIACYLGLYCEROL; ERGOSTEROL; FARNESOL; ICOSANOID; LACCASE; MELANIN; MITOGEN ACTIVATED PROTEIN KINASE; RAS1 PROTEIN; SPHINGOLIPID; UNCLASSIFIED DRUG;

APOPTOSIS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER; CRYPTOCOCCUS NEOFORMANS; FUNGAL VIRULENCE; MELANOGENESIS; MYCOSIS; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEROL SYNTHESIS; TRANSCRIPTION INITIATION; VIRULENCE;

EICOSANOIDS; FARNESOL; FUNGI; LIPID METABOLISM; MODELS, BIOLOGICAL; QUORUM SENSING; SIGNAL TRANSDUCTION; SPHINGOLIPIDS;

ASPERGILLUS; CANDIDA; FUNGI;

EID: 70349527944     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.091208.073431     Document Type: Review

References (69)

1. Alem MA, Douglas LJ. 2005. Prostaglandin production during growth of Candida albicans biofilms. J. Med. Microbiol. 54:001-5
2. Bordon AP, Dias-Melicio LA, Acorci MJ, Biondo GA, Fecchio D, et al. 2007. Prostaglandin E(2) production by high and low virulent strains of Paracoccidioides brasiliensis. Mycopathologia 163:129-135 (Pubitemid 46474878)
3. Braun BR, Johnson AD. 1997. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277:105-109
4. Braun BR, Johnson AD. 2000. TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics 155:57-67
5. Braun BR, Kadosh D, Johnson AD. 2001. NRG1, a repressor of filamentous growth in C. albicans, is down-regulated during filament induction. EMBO J. 20:4753-4761 (Pubitemid 32848628)
6. Cao YY, Cao YB, Xu Z, Ying K, Li Y, et al. 2005. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob. Agents Chemother. 49:584-589 (Pubitemid 40175666)
7. Cenci E, Francisci D, Belfiori B, Pierucci S, Baldelli F, et al. 2008. Tipranavir exhibits different effects on opportunistic pathogenic fungi. J. Infect. 56:58-64 (Pubitemid 350258320)
8. Cho T, Aoyama T, Toyoda M, Nakayama H, Chibana H, Kaminishi H. 2007. Transcriptional changes in Candida albicans genes by both farnesol and high cell density at an early stage of morphogenesis in N-acetyl-D-glucosamine medium. Nippon Ishinkin Gakkai. Zasshi 48:159-167
9. Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, et al. 2001. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol. Microbiol. 39:166-175 (Pubitemid 32057686)
10. Cugini C, Calfee MW, Farrow JM 3rd, Morales DK, Pesci EC, Hogan DA. 2007. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol. Microbiol. 65:896-906
11. Cushion MT, Collins MS, Linke MJ. 2008. Biofilm formation by Pneumocystis. Eukaryot. Cell 8:197-206
12. Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA. 2008. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signaling pathway and the regulation of morphogenesis. Mol. Microbiol. 67:47-62 (Pubitemid 350231134)
13. Deva R, Ciccoli R, Schewe T, Kock JL, Nigam S. 2000. Arachidonic acid stimulates cell growth and forms a novel oxygenated metabolite in Candida albicans. Biochim. Biophys. Acta 1486:299-311 (Pubitemid 30618870)
14. Enjalbert B, Whiteway M. 2005. Release from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growth. Eukaryot. Cell 4:1203-1210 (Pubitemid 41004133)
15. Erb-Downward JR, Huffnagle GB. 2007. Cryptococcus neoformans produces authentic prostaglandin E2 without a cyclooxygenase. Eukaryot. Cell 6:346-350
16. Erb-Downward JR, Noggle RM, Williamson PR, Huffnagle GB. 2008. The role of laccase in prostaglandin production by Cryptococcus neoformans. Mol. Microbiol. 68:1428-1437
17. Erb-Downward JR, Noverr MC. 2007. Characterization of prostaglandin E2 production by Candida albicans. Infect. Immun. 75:3498-3505 (Pubitemid 47040951)
18. Feng Q, Summers E, Guo B, Fink G. 1999. Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J. Bacteriol. 181:6339-6346 (Pubitemid 29512943)
19. Garcia J, Shea J, Alvarez-Vasquez F, Qureshi A, Luberto C, et al. 2008. Mathematical modeling of pathogenicity of Cryptococcus neoformans. Mol. Syst. Biol. 4:183 (Pubitemid 351543592)
20. Gerik KJ, Bhimireddy SR, Ryerse JS, Specht CA, Lodge JK. 2008. PKC1 is essential for protection against both oxidative and nitrosative stresses, cell integrity, and normal manifestation of virulence factors in the pathogenic fungus Cryptococcus neoformans. Eukaryot. Cell 7:1685-1698
21. Gerik KJ, Donlin MJ, Soto CE, Banks AM, Banks IR, et al. 2005. Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. Mol. Microbiol. 58:393-408
22. Haas-Stapleton EJ, Lu Y, Hong S, Arita M, Favoreto S, et al. 2007. Candida albicans modulates host defense by biosynthesizing the proresolving mediator resolvin E1. PLoS ONE 2:e1316 (Pubitemid 351766829)
23. Henriques M, Martins M, Azeredo J, Oliveira R. 2007. Effect of farnesol on Candida dubliniensis morphogenesis. Lett. Appl. Microbiol. 44:199-205 (Pubitemid 46146592)
24. Heung LJ, Kaiser AE, Luberto C, Del Poeta M. 2005. The role and mechanism of diacylglycerol-protein kinase C1 signaling in melanogenesis by Cryptococcus neoformans. J. Biol. Chem. 280:28547-28555 (Pubitemid 41105755)
25. Heung LJ, Luberto C, Plowden A, Hannun YA, Del Poeta M. 2004. The sphingolipid pathway regulates Pkc1 through the formation of diacylglycerol in Cryptococcus neoformans. J. Biol. Chem. 279:21144-21153 (Pubitemid 38656517)
26. Hornby JM, Jensen EC, Lisec AD, Tasto JJ, Jahnke B, et al. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2982-2992 (Pubitemid 33644762)
27. Hornby JM, Nickerson KW. 2004. Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob. Agents Chemother. 48:2305-2307
28. Hurley JH, Newton AC, Parker PJ, Blumberg PM, Nishizuka Y. 1997. Taxonomy and function of C1 protein kinase C homology domains. Protein Sci. 6:477-480 (Pubitemid 27079944)
29. Kadosh D, Johnson AD. 2001. Rfg1, a protein related to the Saccharomyces cerevisiae hypoxic regulator Rox1, controls filamentous growth and virulence in Candida albicans. Mol. Cell Biol. 21:2496-2505 (Pubitemid 32222102)
30. Kaneko A, Umeyama T, Utena-Abe Y, Yamagoe S, Niimi M, Uehara Y. 2006. Tcc1p, a novel protein containing the tetratricopeptide repeat motif, interacts with Tup1p to regulate morphological transition and virulence in Candida albicans. Eukaryot. Cell 5:1894-1905 (Pubitemid 44778452)
31. Kebaara BW, Langford ML, Navarathna DH, Dumitru R, Nickerson KW, Atkin AL. 2008. Candida albicans Tup1 is involved in farnesol-mediated inhibition of filamentous-growth induction. Eukaryot. Cell 7:980-987 (Pubitemid 351961577)
32. Kechichian TB, Shea J, Del Poeta M. 2007. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect. Immun. 75:4792-4798 (Pubitemid 47502148)
33. Khalaf RA, Zitomer RS. 2001. The DNA binding protein Rfg1 is a repressor of filamentation in Candida albicans. Genetics 157:1503-1512 (Pubitemid 32298820)
34. Kruppa M, Krom BP, Chauhan N, Bambach AV, Cihlar RL, Calderone RA. 2004. The two-component signal transduction protein Chk1p regulates quorum sensing in Candida albicans. Eukaryot. Cell 3:1062-1065 (Pubitemid 39098881)
35. Leberer E, Harcus D, Dignard D, Johnson L, Ushinsky S, et al. 2001. Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and cAMP signaling pathways in the pathogenic fungus Candida albicans. Mol. Microbiol. 42:673-687 (Pubitemid 33064478)
36. Levitin A, Whiteway M. 2007. The effect of prostaglandin E2 on transcriptional responses of Candida albicans. Microbiol. Res. 162:201-210 (Pubitemid 46977667)
37. Lorek J, Poggeler S, Weide MR, Breves R, Bockmuhl DP. 2008. Influence of farnesol on the morphogenesis of Aspergillus niger. J. Basic Microbiol. 48:99-103
38. Lorenz MC, Bender JA, Fink GR. 2004. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot. Cell 3:1076-1087
39. Luberto C, Martinez-Marino B, Taraskiewicz D, Bolanos B, Chitano P, et al. 2003. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J. Clin. Investig. 112:1080-1094 (Pubitemid 38056323)
40. Luberto C, Toffaletti DL, Wills EA, Tucker SC, Casadevall A, et al. 2001. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev. 15:201-212 (Pubitemid 32107665)
41. Martin SW, Konopka JB. 2004. Lipid raft polarization contributes to hyphal growth in Candida albicans. Eukaryot. Cell 3:675-684
42. McAlester G, O'Gara F, Morrissey JP. 2008. Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans. J. Med. Microbiol. 57:563-569 (Pubitemid 351632902)
43. Mosel DD, Dumitru R, Hornby JM, Atkin AL, Nickerson KW. 2005. Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum. Appl. Environ. Microbiol. 71:4938-4940 (Pubitemid 41129562)
44. Murad AM, Leng P, Straffon M, Wishart J, Macaskill S, et al. 2001. NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J. 20:4742-4752 (Pubitemid 32848627)
45. Navarathna DH, Hornby JM, Hoerrmann N, Parkhurst AM, Duhamel GE, Nickerson KW. 2005. Enhanced pathogenicity of Candida albicans pretreated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. J. Antimicrob. Chemother. 56:1156-1159 (Pubitemid 43009840)
46. Navarathna DH, Hornby JM, Krishnan N, Parkhurst A, Duhamel GE, Nickerson KW. 2007. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect. Immun. 75:1609-1618 (Pubitemid 46559424)
47. Navarathna DH, Nickerson KW, Duhamel GE, Jerrels TR, Petro TM. 2007. Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model. Infect. Immun. 75:4006-4011
48. Noverr MC, Cox GM, Perfect JR, Huffnagle GB. 2003. Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect. Immun. 71:1538-1547
49. Noverr MC, Phare SM, Toews GB, Coffey MJ, Huffnagle GB. 2001. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect. Immun. 69:2957-2963
50. Noverr MC, Toews GB, Huffnagle GB. 2002. Production of prostaglandins and leukotrienes by pathogenic fungi. Infect. Immun. 70:400-402 (Pubitemid 34028641)
51. Ozpolat B, Akar U, Mehta K, Lopez-Berestein G. 2007. PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells. Autophagy 3:480-483 (Pubitemid 47293733)
52. Perumal P, Mekala S, Chaffin WL. 2007. Role for cell density in antifungal drug resistance in Candida albicans biofilms. Antimicrob. Agents Chemother. 51:2454-2463 (Pubitemid 47047324)
53. Rhome R, McQuiston T, Kechichian T, Bielawska A, Hennig M, et al. 2007. Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens. Eukaryot. Cell 6:1715-1726 (Pubitemid 47592097)
54. Rittershaus PC, Kechichian TB, Allegood JC, Merrill AH Jr, Hennig M, et al. 2006. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. J. Clin. Investig. 116:1651-1659 (Pubitemid 43911019)
55. Rossignol T, Logue ME, Reynolds K, Grenon M, Lowndes NF, Butler G. 2007. Transcriptional response of Candida parapsilosis following exposure to farnesol. Antimicrob. Agents Chemother. 51:2304-2312 (Pubitemid 47047304)
56. Sato T, Watanabe T, Mikami T, Matsumoto T. 2004. Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogenactivated protein kinase cascade. Biol. Pharm. Bull. 27:751-752 (Pubitemid 41694687)
57. Semighini CP, Hornby JM, Dumitru R, Nickerson KW, Harris SD. 2006. Farnesol-induced apoptosis in Aspergillus nidulans reveals a possible mechanism for antagonistic interactions between fungi. Mol. Microbiol. 59:753-764
58. Shchepin R, Navarathna DH, Dumitru R, Lippold S, Nickerson KW, Dussault PH. 2008. Influence of heterocyclic and oxime-containing farnesol analogs on quorum sensing and pathogenicity in Candida albicans. Bioorg. Med. Chem. 16:1842-1848 (Pubitemid 351226584)
59. Shea JM, Kechichian TB, Luberto C, Del Poeta M. 2006. The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect. Immun. 74:5977-5988 (Pubitemid 44484585)
60. Siafakas AR, Sorrell TC, Wright LC, Wilson C, Larsen M, et al. 2007. Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity. J. Biol. Chem. 282:37508-37514
61. Stano P, Williams V, Villani M, Cymbalyuk ES, Qureshi A, et al. 2009. App1: an antiphagocytic protein that binds to complement receptors 3 and 2. J. Immunol. 182:84-91
62. Tommasino N, Villani M, Qureshi A, Henry J, Luberto C, Del Poeta M. 2008. Atf2 transcription factor binds to the APP1 promoter in Cryptococcus neoformans: stimulatory effect of diacylglycerol. Eukaryot. Cell 7:294-301 (Pubitemid 351959696)
63. Tsitsigiannis DI, Bok JW, Andes D, Nielsen KF, Frisvad JC, Keller NP. 2005. Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence. Infect. Immun. 73:4548-4559 (Pubitemid 41105609)
64. Tsuchimori N, Sharkey LL, Fonzi WA, French SW, Edwards JE Jr, Filler SG. 2000. Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells. Infect. Immun. 68:1997-2002 (Pubitemid 30164829)
65. van Ooij C, Kalman L, van Ijzendoorn, Nishijima M, Hanada K, et al. 2000. Host cell-derived sphingolipids are required for the intracellular growth of Chlamydia trachomatis. Cell Microbiol. 2:627-637 (Pubitemid 32049331)
66. Weber K, Sohr R, Schulz B, Fleischhacker M, Ruhnke M. 2008. Secretion of E,E-farnesol and biofilm formation in eight different Candida species. Antimicrob. Agents Chemother. 52:1859-1861 (Pubitemid 351614688)
67. Westwater C, Balish E, Schofield DA. 2005. Candida albicans-conditioned medium protects yeast cells from oxidative stress: a possible link between quorum sensing and oxidative stress resistance. Eukaryot. Cell 4:1654-1661 (Pubitemid 41484225)
68. Wright LC, Santangelo RM, Ganendren R, Payne J, Djordjevic JT, Sorrell TC. 2007. Cryptococcal lipid metabolism: Phospholipase B1 is implicated in transcellular metabolism of macrophage-derived lipids. Eukaryot. Cell 6:37-47 (Pubitemid 46147651)
69. Zheng X, Wang Y. 2004. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J. 23:1845-1856 (Pubitemid 38649647)